These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17119038)

  • 1. CYP17 genotypes differ in salivary 17-beta estradiol levels: a study based on hormonal profiles from entire menstrual cycles.
    Jasienska G; Kapiszewska M; Ellison PT; Kalemba-Drozdz M; Nenko I; Thune I; Ziomkiewicz A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2131-5. PubMed ID: 17119038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses do not support CYP17 genotype-estradiol associations.
    Vitzthum VJ; Thornburg J
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1550; author reply 1550. PubMed ID: 18559574
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic polymorphism CYP17 rs2486758 and metabolic risk factors predict daily salivary 17β-estradiol concentration in healthy premenopausal Norwegian women. The EBBA-I study.
    Iversen A; Thune I; McTiernan A; Makar KW; Wilsgaard T; Ellison PT; Jasienska G; Flote V; Poole EM; Furberg AS
    J Clin Endocrinol Metab; 2012 May; 97(5):E852-7. PubMed ID: 22419734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.
    Feigelson HS; Shames LS; Pike MC; Coetzee GA; Stanczyk FZ; Henderson BE
    Cancer Res; 1998 Feb; 58(4):585-7. PubMed ID: 9485002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
    Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
    Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
    Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
    Haiman CA; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1999 Mar; 59(5):1015-20. PubMed ID: 10070957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyp17, urinary sex steroid levels and breast cancer risk in postmenopausal women.
    Onland-Moret NC; van Gils CH; Roest M; Grobbee DE; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):815-20. PubMed ID: 15824149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
    Henningson M; Johansson U; Borg A; Olsson H; Jernström H
    Mol Hum Reprod; 2007 Apr; 13(4):231-6. PubMed ID: 17307805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
    Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
    Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP17 genotype predicts serum hormone levels among pre-menopausal women.
    Small CM; Marcus M; Sherman SL; Sullivan AK; Manatunga AK; Feigelson HS
    Hum Reprod; 2005 Aug; 20(8):2162-7. PubMed ID: 15878919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?
    Berstein LM; Imyanitov EN; Gamajunova VB; Kovalevskij AJ; Kuligina ESh; Belogubova EV; Buslov KG; Karpova MB; Togo AV; Volkov ON; Kovalenko IG
    Cancer Lett; 2002 Jun; 180(1):47-53. PubMed ID: 11911969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
    Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
    Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in CYP17 and endometrial cancer risk.
    Haiman CA; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
    Cancer Res; 2001 May; 61(10):3955-60. PubMed ID: 11358812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.
    Sata F; Yamada H; Yamada A; Kato EH; Kataoka S; Saijo Y; Kondo T; Tamaki J; Minakami H; Kishi R
    Mol Hum Reprod; 2003 Nov; 9(11):725-8. PubMed ID: 14561815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
    Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
    Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP17 genotype modifies the impact of anthropometric variation on salivary estradiol in healthy women.
    Rowe E; Van Horn A; Rockwell LC
    Am J Phys Anthropol; 2015 Apr; 156(4):665-70. PubMed ID: 25448501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
    Haiman CA; Stampfer MJ; Giovannucci E; Ma J; Decalo NE; Kantoff PW; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):743-8. PubMed ID: 11440959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymorhism of CYP17 gene and age of menarche].
    Kulik-Rechberger B; Skorupski P; Bogusiewicz M; Miotła P; Rechberger T
    Ginekol Pol; 2007 Dec; 78(12):929-32. PubMed ID: 18411914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women.
    Gorai I; Tanaka K; Inada M; Morinaga H; Uchiyama Y; Kikuchi R; Chaki O; Hirahara F
    J Clin Endocrinol Metab; 2003 Feb; 88(2):799-803. PubMed ID: 12574216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.